The 4G/5G Polymorphism in the Plasminogen Activator Inhibitor-1 Gene Is not Associated with Myocardial Infarction

Doggen, C.J.M. and Bertina, R.M. and Manger Cats, V. and Reitsma, P.H. and Rosendaal, F.R. (1999) The 4G/5G Polymorphism in the Plasminogen Activator Inhibitor-1 Gene Is not Associated with Myocardial Infarction. Thrombosis and Haemostasis, 82 (1). pp. 115-120. ISSN 0340-6245

Preview

PDF
66Kb

Abstract:	Several studies have found an association between high plasminogenactivator inhibitor-1 (PAI-1) levels and myocardial infarction.Whether this is causal or a consequence of atherosclerosis or tissuedamage, remains unclear. Homozygous carriers of the 4G allele of the4G/5G polymorphism in the PAI-1 gene have higher PAI-1 levels comparedto carriers of the 5G allele in healthy persons in some studies, butnot all. If PAI-1 levels are causally related to myocardial infarction, onewould expect more homozygous carriers of the 4G allele among patients,provided that these carriers have high PAI-1 levels among healthypersons in that population. We investigated the distribution of this polymorphismin the "Study of Myocardial Infarctions Leiden" (SMILE),including 331 men with a myocardial infarction and 302 controlsubjects and measured PAI-1 antigen levels among the latter. Secondly,we looked into the association of cardiovascular risk factors withPAI-1 levels.We did not find an increase in risk of myocardial infarction in carriersof the 4G allele. Neither did we find an association, nor a trend,between the 4G/5G polymorphism and PAI-1 antigen levels in controlsubjects. Controls with obesity, hypertension, or who smoked had significanthigher PAI-1 antigen levels compared with persons withoutthese factors. High cholesterol and triglyceride levels were also associatedwith high PAI-1 antigen levels, and HDL-cholesterol levelsshowed an inverse association.We conclude that the 4G/5G polymorphism in the PAI-1 gene is notassociated with the risk of myocardial infarction. As we did not findany association between this polymorphism and PAI-1 antigen levels inhealthy persons, we cannot draw any conclusions about the causality ofPAI-1 itself for myocardial infarction
Item Type:	Article
Copyright:	© Schattauer Publishers
Link to this item:	http://purl.utwente.nl/publications/77855
Official URL:	http://www.schattauer.de/de/magazine/uebersicht/zeitschriften-a-z/thrombosis-and-haemostasis/contents/archive/issue/901/manuscript/4900/show.html
Export this item as:	BibTeX EndNote HTML Citation Reference Manager

Show download statistics for this publication

Repository Staff Only: item control page